Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Price:
35.97 CNY
-1.13%
Market Closed
Updated:
Jun 9, 2024
Tibet Rhodiola Pharmaceutical Holding Co
Total Assets
|
Tibet Rhodiola Pharmaceutical Holding Co
Total Assets Peer Comparison
Comparables:
1099
601607
600998
C
600511
000963
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Total Assets
¥4.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Total Assets
¥417.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Total Assets
¥212B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Total Assets
¥92.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
16%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Total Assets
¥32.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
20%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Total Assets
¥33.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Total Assets?
Total Assets
4.6B
CNY
4.6B
CNY
Based on the financial report for Mar 31, 2024, Tibet Rhodiola Pharmaceutical Holding Co's Total Assets amounts to 4.6B CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Total Assets growth rate?
Total Assets CAGR 10Y
15%
15%
Over the last year, the Total Assets growth was -2%. The average annual Total Assets growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been 12% over the past three years , 12% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
